Amedeo's Top 20

Amedeo Smart

Independent Medical Education

12 January 2015

Multidisciplinary Journal Club

  1. Kalincik T, Horakova D, Spelman T, Jokubaitis V, et al.
    Switch to natalizumab vs fingolimod in active relapsing-remitting multiple sclerosis.
    Ann Neurol 2014.

  1. Freireich EJ, Wiernik PH, Steensma DP.
    The leukemias: a half-century of discovery.
    J Clin Oncol 2014;32:3463-9.

  2. Guo H, Baker S, Martinez-Sobrido L, Topham DJ, et al.
    Induction of CD8 T Cell Heterologous Protection by a Single Dose of Single-cycle Infectious Influenza Virus.
    J Virol 2014.

  3. Black DM, Reid IR, Cauley JA, Cosman F, et al.
    The Effect of 6 versus 9 Years of Zoledronic Acid Treatment in Osteoporosis: A Randomized Second Extension to the HORIZON-Pivotal Fracture Trial (PFT).
    J Bone Miner Res 2014.

  4. Vanders RL , Gibson PG, Murphy VE, Wark PA, et al.
    Plasmacytoid dendritic cells and CD8 T cells from pregnant women show altered phenotype and function following H1N1/09 infection.
    J Infect Dis 2013;208:1062-70.

  1. Datta S, Sherman JM, Bravard MA, Valencia T, et al.
    Clinical evaluation of tuberculosis viability microscopy for assessing treatment response.
    Clin Infect Dis 2014.

  2. Sheehan JP, Yen CP, Lee CC, Loeffler JS, et al.
    Cranial stereotactic radiosurgery: current status of the initial paradigm shifter.
    J Clin Oncol 2014;32:2836-46.

  3. Fanoe S, Kristensen D, Fink-Jensen A, Jensen HK, et al.
    Risk of arrhythmia induced by psychotropic medications: a proposal for clinical management.
    Eur Heart J 2014;35:1306-15.

  4. Guimbaud R, Louvet C, Ries P, Ychou M, et al.
    Prospective, randomized, multicenter, phase III study of fluorouracil, leucovorin, and irinotecan versus epirubicin, cisplatin, and capecitabine in advanced gastric adenocarcinoma: a French intergroup (Federation Francophone de %0
    J Clin Oncol 2014;32:3520-6.

  5. Wabitsch M, Funcke JB, Lennerz B, Kuhnle-Krahl U, et al.
    Biologically inactive leptin and early-onset extreme obesity.
    N Engl J Med 2015;372:48-54.

  1. Canning CG, Sherrington C, Lord SR, Close JC, et al.
    Exercise for falls prevention in Parkinson disease: A randomized controlled trial.
    Neurology 2014.

  2. Crump M, Kuruvilla J, Couban S, MacDonald DA, et al.
    Randomized comparison of gemcitabine, dexamethasone, and cisplatin versus dexamethasone, cytarabine, and cisplatin chemotherapy before autologous stem-cell transplantation for relapsed and refractory aggressive lymphomas: NCIC-CTG LY.12.
    J Clin Oncol 2014;32:3490-6.

  3. Blackhall FH, Peters S, Bubendorf L, Dafni U, et al.
    Prevalence and clinical outcomes for patients with ALK-positive resected stage I to III adenocarcinoma: results from the European Thoracic Oncology Platform Lungscape Project.
    J Clin Oncol 2014;32:2780-7.

  4. Zhang Q, Wang C, Zheng M, Li Y, et al.
    Aspirin plus Clopidogrel as Secondary Prevention after Stroke or Transient Ischemic Attack: A Systematic Review and Meta-Analysis.
    Cerebrovasc Dis 2014;39:13-22.

  5. Surichan S , Wirachwong P, Supachaturas W, Utid K, et al.
    Development of influenza vaccine production capacity by the Government Pharmaceutical Organization of Thailand: Addressing the threat of an influenza pandemic.
    Vaccine 2011;29 S:A29-33.

  1. Lindsley RC, Mar BG, Mazzola E, Grauman PV, et al.
    Acute myeloid leukemia ontogeny is defined by distinct somatic mutations.
    Blood 2014.

  2. Okonkwo OC, Schultz SA, Oh JM, Larson J, et al.
    Physical activity attenuates age-related biomarker alterations in preclinical AD.
    Neurology 2014;83:1753-60.

  3. Charytan DM, Pai AB, Chan CT, Coyne DW, et al.
    Considerations and Challenges in Defining Optimal Iron Utilization in Hemodialysis.
    J Am Soc Nephrol 2014.

  4. Kierkegaard M , Einarsson U, Gottberg K, von Koch L, et al.
    The relationship between walking, manual dexterity, cognition and activity/participation in persons with multiple sclerosis.
    Mult Scler 2011.

  5. Genuth S.
    Should Sulfonylureas Remain an Acceptable First-Line Add-on to Metformin Therapy in Patients With Type 2 Diabetes? No, It's Time to Move On!
    Diabetes Care 2015;38:170-5.


Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016